Tikun Olam Cannbit Pharmaceuticals Ltd (TKUN) - Cash Flow Conversion Efficiency

Latest as of June 2023: -0.082x

Based on the latest financial reports, Tikun Olam Cannbit Pharmaceuticals Ltd (TKUN) has a cash flow conversion efficiency ratio of -0.082x as of June 2023. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (ILA-4.35 Million ≈ $-11.66K USD) by net assets (ILA53.22 Million ≈ $142.69K USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.

Tikun Olam Cannbit Pharmaceuticals Ltd - Cash Flow Conversion Efficiency Trend (2017–2024)

This chart illustrates how Tikun Olam Cannbit Pharmaceuticals Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data. Read Tikun Olam Cannbit Pharmaceuticals Ltd (TKUN) financial obligations for a breakdown of total debt and financial obligations.

Tikun Olam Cannbit Pharmaceuticals Ltd Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Tikun Olam Cannbit Pharmaceuticals Ltd ranked by their cash flow conversion efficiency.

Company	Cash Flow Conversion Efficiency
Communication & System Solution Public Company Limited BK:CSS	0.010x
Optrontec Inc KQ:082210	-0.058x
Synergy House Berhad KLSE:0279	0.111x
Skin n Skin Co. Ltd KQ:159910	-0.211x
ABVC Biopharma Inc NASDAQ:ABVC	-0.044x
Madison Pacific Properties Inc. TO:MPC	0.008x
Softing AG XETRA:SYT	-0.003x
Okong Corporation KQ:045060	0.044x

Annual Cash Flow Conversion Efficiency for Tikun Olam Cannbit Pharmaceuticals Ltd (2017–2024)

The table below shows the annual cash flow conversion efficiency of Tikun Olam Cannbit Pharmaceuticals Ltd from 2017 to 2024. For the full company profile with market capitalisation and key ratios, see market cap of Tikun Olam Cannbit Pharmaceuticals Ltd.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2024-12-31	ILA-5.35 Million ≈ $-14.34K	ILA-3.77 Million ≈ $-10.11K	0.705x	+870.69%
2023-12-31	ILA33.04 Million ≈ $88.59K	ILA-3.02 Million ≈ $-8.11K	-0.092x	+41.26%
2022-12-31	ILA116.92 Million ≈ $313.46K	ILA-18.22 Million ≈ $-48.84K	-0.156x	+3.30%
2021-12-31	ILA143.82 Million ≈ $385.59K	ILA-23.17 Million ≈ $-62.13K	-0.161x	+10.07%
2020-12-31	ILA136.06 Million ≈ $364.77K	ILA-24.38 Million ≈ $-65.36K	-0.179x	-433.18%
2019-12-31	ILA99.87 Million ≈ $267.75K	ILA-3.36 Million ≈ $-9.00K	-0.034x	+99.79%
2018-12-31	ILA108.00K ≈ $289.54	ILA-1.76 Million ≈ $-4.71K	-16.278x	-7635.02%
2017-12-31	ILA-492.00K ≈ $-1.32K	ILA-106.29K ≈ $-284.95	0.216x	--

About Tikun Olam Cannbit Pharmaceuticals Ltd

TA:TKUN Israel Drug Manufacturers - Specialty & Generic

Market Cap

$420.72 Million

ILA156.93 Billion ILA

Market Cap Rank

#23910 Global

#342 in Israel

Share Price

ILA1847.00

Change (1 day)

+2.21%

52-Week Range

ILA17.03 - ILA2371.00

All Time High

ILA7500.00